CS-08399

N/A

Report date: 2026/05/14 20:00:28
NME

Base Information

Drug NameCS-08399
Drug Alias NameCS08399
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEpigenetic regulationProtein arginine methyltransferase 5 modulators
TargetsProtein arginine methyltransferase 5
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungPancreatic Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShenzhen Chipscreen Biosciences Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesChengdu Chipscreen Pharmaceutical Co LtdChipscreen Biosciences Ltd
Inactive CompaniesShenzhen Chipscreen Biosciences Co Ltd
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungPancreatic Neoplasms +[5] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A